Please assess the completion status of the following clinical trial:

Trial Title: Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Age greater than or equal to 18 years~2. Clinical need for percutaneous coronary intervention using either a Xience, Promus Element, or Resolute Integrity drug-eluting stent using optical coherence tomography optimization~3. Native coronary artery de novo lesion with ≥70% angiographic percent diameter stenosis by visual estimation~4. Target vessel reference diameter between 2.5 and 4.0 mm by visual estimate~5. Target lesion ≤28 mm in length by visual estimate~6. Agree to participate and provide informed consent~Exclusion Criteria:~1.Presentation with acute ST-elevation myocardial infarction (defined as electrocardiographic (ECG) ST-elevation ≥ 2 mm in 2 or more contiguous ECG leads along with symptoms compatible with ischemia)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Xience EES (Type: ACTIVE_COMPARATOR): This arm of patients will receive Xience Everolimus Eluting Stents(EES) as part of their clinically indicated PCI procedure and they will undergo Optical Coherence Tomography Imaging
- Resolute Integrity ZES (Type: ACTIVE_COMPARATOR): This arm of patients will receive Resolute Integrity Zotaralimus Eluting Stents (ZES) as part of their clinically indicated PCI procedure and they will undergo Optical Coherence Tomography Imaging
- Promus Element EES (Type: ACTIVE_COMPARATOR): This arm of patients will receive Promus Element Everolimus Eluting Stents (EES) as part of their clinically indicated PCI procedure and they will undergo Optical Coherence Tomography Imaging

Based on this trial design, predict the completion outcome and termination type (if applicable).